Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Alkermes plc
  6. News
  7. Summary
    ALKS   IE00B56GVS15

ALKERMES PLC

(ALKS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Trying to Make Gains Ahead of Tuesday Opener

06/01/2021 | 09:10am EDT


© MT Newswires 2021
All news about ALKERMES PLC
07/21ALKERMES : to Report Second Quarter 2021 Financial Results on July 28, 2021
PR
06/30ALKERMES : Presented New Data Analysis on Healthcare Resource Use Among Veterans..
PR
06/30Alkermes Presents New Data Analysis on Healthcare Resource Use Among Veterans..
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 3000E Growth Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) dropped from Russell 1000 Dynamic Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) dropped from Russell 1000 Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 2000 Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 2000 Defensive Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 2000 Growth-Defensive Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 2000 Dynamic Index
CI
More news
Financials (USD)
Sales 2021 1 140 M - -
Net income 2021 -106 M - -
Net cash 2021 333 M - -
P/E ratio 2021 -37,0x
Yield 2021 -
Capitalization 3 875 M 3 875 M -
EV / Sales 2021 3,11x
EV / Sales 2022 2,78x
Nbr of Employees 2 245
Free-Float 96,7%
Chart ALKERMES PLC
Duration : Period :
Alkermes plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALKERMES PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 24,15 $
Average target price 22,78 $
Spread / Average Target -5,68%
EPS Revisions
Managers and Directors
Richard F. Pops Chairman & Chief Executive Officer
Iain Michael Brown Senior VP, Chief Financial & Accounting Officer
Craig C. Hopkinson Chief Medical Officer & EVP-Research & Development
Thomas Harvey Chief Information Officer & Senior VP-IT
Sondra Smyrnios Senior Vice President-Clinical Operations
Sector and Competitors
1st jan.Capi. (M$)
ALKERMES PLC21.05%3 872
MODERNA, INC.209.64%88 312
LONZA GROUP AG19.02%53 538
IQVIA HOLDINGS INC.36.69%47 022
CELLTRION, INC.-25.21%32 170
SEAGEN INC.-18.16%28 525